Orion OYJ (OTCMKTS:ORINY) Releases Quarterly Earnings Results

Orion OYJ (OTCMKTS:ORINY) posted its quarterly earnings data on Wednesday. The company reported $0.68 earnings per share for the quarter, Zacks reports.

Orion OYJ Stock Performance

Shares of ORINY stock traded down $0.78 on Wednesday, reaching $54.00. The stock had a trading volume of 900 shares, compared to its average volume of 1,249. Orion OYJ has a 1 year low of $30.89 and a 1 year high of $56.05. The company has a 50 day simple moving average of $47.15 and a 200 day simple moving average of $41.36.

Analyst Ratings Changes

Separately, Jefferies Financial Group raised shares of Orion OYJ from a “hold” rating to a “strong-buy” rating in a research note on Monday. One investment analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Buy”.

Orion OYJ Company Profile

Orion Oyj, also known as Orion Corporation, is a Finnish pharmaceutical company that develops, manufactures and markets human and veterinary medicines. Its portfolio includes prescription medicines, over-the-counter products, generic pharmaceuticals and active pharmaceutical ingredients.

The company focuses on several therapeutic areas, including central nervous system disorders, oncology, respiratory diseases, pain management and veterinary medicine. Orion is particularly recognized for treatments related to Parkinson’s disease, as well as its Easyhaler line of inhaled medicines for respiratory conditions.

Founded in Finland in 1917, Orion is headquartered in Espoo.